Can the Elderly Handle the Heat? A Retrospective Case-Control Study of the Impact of Heat Waves on Older Patients Attending an Inner City Australian Emergency Department

2012 ◽  
Vol 27 (2) ◽  
pp. NP1837-NP1846 ◽  
Author(s):  
Janelle Dalip ◽  
Georgina A. Phillips ◽  
George A. Jelinek ◽  
Tracey J. Weiland
Author(s):  
Emre Göksan Pabuçcu ◽  
Aslı Yarcı Gürsoy ◽  
Hasan Ulubaşoğlu ◽  
Özgür Doğuş Demirkıran ◽  
Gamze Sinem Çağlar ◽  
...  

<p><strong>OBJECTIVE:</strong> To compare oocyte yield of women with intact ovarian endometrioma(s) to those without endometrioma undergoing ART. Secondary outcomes were implantation and live birth rates between the two groups.</p><p><strong>STUDY DESIGN: </strong>Retrospective case-control study was conducted to document eligible cases. A total of 165 women with intact endometrioma(s) (END) were included in the final analysis. Controls were 196 cases with tubal disease as the sole cause of their infertility who underwent ART in the same time period. Cases and controls were matched for age, BMI and serum AMH concentrations. Ovarian stimulation characteristics and pregnancy outcomes including live birth data were documented for both groups.</p><p><strong>RESULTS: </strong>Despite similar demographic characteristics, significantly<strong> </strong>longer cycle duration and higher amounts of gonadotropin consumption was observed in END group compared to controls (p&lt;0.001). Significantly lower numbers of retrieved oocytes, mature oocytes and mature oocyte fraction (%, no of retrieved/mature) was detected in END group. There was no statistically significant difference in terms of fertilization, implantation and live birth rate per started cycle among groups. Cycle cancellations were also similar.</p><p><strong>CONCLUSION: </strong>In women with intact ovarian endometrioma(s) undergoing ART, oocyte quantity, especially mature oocyte yield was hampered. However, adequate number of mature oocytes, successful fertilization and satisfactory implantation rates might be possible contributing to acceptable live births. Further randomized controlled trials of patients with different sizes of endometrioma(s) would be needed to confirm our conclusions.</p>


2020 ◽  
Author(s):  
Kwanghee Jun ◽  
Yujin Kim ◽  
Young-Mi Ah ◽  
Ju-Yeun Lee

Abstract Background Cautious use or avoidance of hyponatraemia-inducing medications (HIMs) is recommended in older patients with hyponatraemia. Objective To evaluate the use of HIMs after treatment for symptomatic or severe hyponatraemia and to investigate the impact of HIMs on the recurrence of symptomatic or severe hyponatraemia in older patients. Design and settings A cross-sectional and nested case–control study using data obtained from national insurance claims databases. Methods The rate of prescribing HIMs during the 3 months before and after the established index date was analysed in a cross-sectional analysis. Multivariable logistic regression was performed to investigate the association between HIM use and recurrence of symptomatic or severe hyponatraemia after adjusting for covariates in a case–control study. Results The cross-sectional study included 1,072 patients treated for symptomatic or severe hyponatraemia. The proportion of patients prescribed any HIMs after hyponatraemia treatment decreased from 76.9 to 70.1%. The prescription rates significantly decreased for thiazide diuretics (from 41.9 to 20.8%) and desmopressin (from 8.6 to 4.0%), but the proportion of patients prescribed antipsychotics increased from 9.2 to 17.1%. Of 32,717 patients diagnosed with hyponatraemia, 913 (2.8%) showed recurrent hyponatraemia. After adjusting for comorbid conditions, the use of any HIMs including proton pump inhibitors [adjusted odds ratio (aOR) 1.34, 95% confidence interval (CI) 1.15–1.57] and two or more HIMs (aOR 1.48, 95% CI 1.22–1.78) especially in combination with thiazide diuretics increased the likelihood of severe hyponatraemia recurrence. Conclusions Prevalent use of HIMs after treatment for symptomatic or severe hyponatraemia and multiple HIM use increase the risk of recurrent hyponatraemia in geriatric patients.


2016 ◽  
Vol 66 (1) ◽  
Author(s):  
Fabrizio Corsini ◽  
Anna Scaglione ◽  
Maria Iacomino ◽  
Giuseppe Mascia ◽  
Saverio Melorio ◽  
...  

Background: ST elevation myocardial infarction (STEMI) in old and old-old patients presents several peculiarities in natural history, delay of hospitalization and response to treatment. Aim of this retrospective case control study was to determine presentation, complications and management of elderly patients with STEMI compared to a younger population. Methods: 462 patients (205 M and 257 F) aged ≥75 years, hospitalized in CCU between 1999 and 2003 for STEMI, were valuated. The control group consisted of 490 consecutive patients (268 M and 222 F) aged 50-70 years. Attention was focused on clinical presentation, complications, management and outcome in elderly compared with younger patients. Results: The mean interval between the onset of symptoms and the arrive in CCU was of 9 hour in the elderly compared to 4,5 hour in the control. Chest pain was less frequent (50% vs 90%) in the elderly; the prevalence of dyspnoea and neurological symptoms was higher in patients &gt;75 years (30% vs 15% and 25% vs 10%). In the elderly, previous angina and AMI, cerebral and peripheral vascular diseases, peripheral and renal failure were frequent. Early severe complications prevailed in the elderly. Thrombolysis was performed only in 39% of the elderly compared to 65% of the control. Significantly higher was cerebral haemorrhage after thrombolysis (4,9% vs 1,8%). Comparable were the mayor extra cranial bleedings. Primary or facilitated PTCA was performed in few patients in the last year. Two weeks mortality was 20%, compared to 6,5% in the control group. Conclusion: The patientes &gt;75 years with STEMI were hospitalized later, had atypical presentation with less chest pain and more cardiac failure, were less likely to receive thrombolysis, had more complications and more cerebral bleedings. Elderly had more associated diseases and in-hospital mortality was higher.


PLoS ONE ◽  
2016 ◽  
Vol 11 (8) ◽  
pp. e0161382 ◽  
Author(s):  
Sepehr Shakib ◽  
Benjamin K. Dundon ◽  
John Maddison ◽  
Josephine Thomas ◽  
Melinda Stanners ◽  
...  

PLoS ONE ◽  
2021 ◽  
Vol 16 (7) ◽  
pp. e0254607
Author(s):  
Nils Wetzstein ◽  
Ari Geil ◽  
Gerrit Kann ◽  
Annette Lehn ◽  
Gundolf Schüttfort ◽  
...  

Introduction Disseminated infection due to non-tuberculous mycobacteria has been a major factor of mortality and comorbidity in HIV patients. Until 2018, U.S. American guidelines have recommended antimycobacterial prophylaxis in patients with low CD4 cell counts, a practice that has not been adopted in Europe. This study aimed at examining the impact of disseminated NTM disease on clinical outcome in German HIV patients with a severe immunodeficiency. Materials and methods In this retrospective case control study, HIV patients with disseminated NTM disease were identified by retrospective chart review and matched by their CD4 cell counts to HIV patients without NTM infection in a 1:1 alocation. Primary endpoints were mortality and time to first rehospitalisation. In addition, other opportunistic diseases, as well as antimycobacterial and antiretroviral treatments were examined. Results Between 2006 and 2016, we identified 37 HIV patients with disseminated NTM disease. Most of them were suffering from infections due to M. avium complex (n = 31, 77.5%). Time to event analysis showed a non-significant trend to higher mortality in patients with disseminated NTM disease (p = 0.24). Rehospitalisation took place significantly earlier in patients with disseminated NTM infections (median 40.5 days vs. 109 days, p<0.0001). Conclusion In this retrospective case control study, we could demonstrate that mortality is not significantly higher in HIV patients with disseminated NTM disease in the ART era, but that they require specialised medical attention in the first months following discharge.


Sign in / Sign up

Export Citation Format

Share Document